ChemicalBook > Product Catalog >Biochemical Engineering >Biochemical Reagents >Agonist Inhibitors >SAR131675

SAR131675

SAR131675 Suppliers list
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel:
Email: sales@boylechem.com
Company Name: Jinan Trio PharmaTech Co., Ltd.  
Tel: 0531-88811783
Email: sales@trio-pharmatech.com
Company Name: SYN|thesis med chem P/L  
Tel: +86-021-50720296
Email: service@synkinase.com
Company Name: Credit Asia Chemical Co., Ltd.  
Tel: +86 (21) 61124340
Email:
Company Name: LETOPHARM LIMITED  
Tel: +86-21-5821 5861
Email: sales@letopharm.com

SAR131675 manufacturers

  • (Rac)-SAR131675
  • (Rac)-SAR131675 pictures
  • $120.00
  • 2026-07-27
  • CAS:1092539-44-0
  • Purity: 99.02%
  • Supply Ability: 10g
  • SAR131675
  • SAR131675 pictures
  • $1.00
  • 2019-12-24
  • CAS:1092539-44-0
  • Min. Order: 1g
  • Purity: 99.99%
  • Supply Ability: 200kg
SAR131675 Basic information
Product Name:SAR131675
Synonyms:SAR131675;SAR131675/SAR-131675;(-)-2-Amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-1,8-naphthyridine-3-carboxamide;(R)-2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1;SAR131675 Racemate;1,8-Naphthyridine-3-carboxamide, 2-amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-, (-)-;2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-n-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide;(Rac)-SAR131675
CAS:1092539-44-0
MF:C18H22N4O4
MW:358.39
EINECS:
Product Categories:
Mol File:1092539-44-0.mol
SAR131675 Structure
SAR131675 Chemical Properties
Melting point >206°C (dec.)
Boiling point 592.2±50.0 °C(Predicted)
density 1.33±0.1 g/cm3(Predicted)
storage temp. Refrigerator
solubility Chloroform (Slightly), DMSO (Slightly)
pka12.20±0.29(Predicted)
form Solid
color White to Pale Yellow
Safety Information
MSDS Information
SAR131675 Usage And Synthesis
UsesSAR131675 is a VEGFR-3 inhibitor with IC50 of 20 nM.
Synthesis
1-Methoxy-2-Methyl-3-butyn-2-ol

42841-64-5

2-AMino-7-chloro-1-ethyl-N-Methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxaMide

1092523-24-4

SAR131675

1092538-80-1

3 g (10.69 mmol) of 2-amino-7-chloro-1-ethyl-N-methyl-4-oxo-1,4-dihydro[1,8]diazanaphthalene-3-carboxamide was suspended in 20 mL of methanol in an 80 mL microwave tube. A DMF/Et3N mixture (V/V; 1/1) was added to the suspension followed by argon bubbling for 10 min. 1.83 g (±)-1-methoxy-2-methyl-3-butyn-2-ol (16.03 mmol), 0.081 g CuI (0.43 mmol), and 0.375 g bis(triphenylphosphine)palladium(II) dichloride (0.53 mmol) were added sequentially. The sealed tube was placed in a microwave reactor (CEM Discover model) and heated at 90 °C for 60 min at 100 W power. After completion of the reaction, the mixture was cooled and evaporated to dryness. The residue was dissolved in mixed ethyl acetate/THF solvent and washed with 0.1 N HCl aqueous solution. The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated in vacuum. The residue was purified by silica gel column chromatography (dry sample, elution gradient: cyclohexane/ethyl acetate, 30:70 to 20:80) to give 2.49 g of light yellow solid product. The product can be recrystallized from ethanol to give white crystals with a melting point of 211 °C. Mass spectrum (MH+): 358. yield: 65%.1H NMR (DMSO-d6, 400 MHz, δ ppm): δ 11.75 (s, <1H, broad peak); 11.00 (q, 1H, broad peak); 8.45 (d, 1H); 8.00 (s, 1H, broad peak); 7.4 (d, 1H); 5.8 (s, 1H); 4.4 (q, 2H); 3.5 (q, 2H). 2H); 3.5-3.3 (m + s, 5H); 2.8 (d, 3H); 1.45 (s, 3H); 1.2 (t, 3H).

IC 50VEGFR3
References[1] Patent: US2010/144757, 2010, A1. Location in patent: Page/Page column 8
Tag:SAR131675(1092539-44-0) Related Product Information
N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide Vandetanib FITC-LABELED VEGFR-2 Protein, HUMAN (HEK293, HIS) VEGFR-1 Protein, RAT (HEK293, HIS) VEGFR-2 Protein, RAT (HEK293, FC) VEGFR-3/FLT4 Protein, HUMAN (HEK293, HIS-AVI)